serotonin
transport
sert
member
neurotransmitt
sodium
symport
nss
famili
respons
reuptak
serotonin
synapt
cleft
maintain
neurotransmitt
homeostasi
sert
establish
import
target
treatment
anxieti
depress
highresolut
crystal
structur
avail
comput
model
sert
built
base
upon
xray
coordin
leucin
transport
leut
bacteri
nss
homolog
model
use
develop
first
sert
structurebas
pharmacophor
virtual
screen
vs
small
molecul
structur
librari
use
gener
sert
comput
model
yield
candid
ligand
divers
scaffold
pharmacolog
analysi
vs
hit
identifi
two
sertselect
compound
potenti
lead
compound
sertrel
medic
develop
signal
cell
central
nervou
system
mediat
control
releas
reuptak
neurotransmitt
synaps
excess
deficit
monoamin
serotonin
dopamin
norepinephrin
synaps
associ
variou
psychiatr
neurolog
disord
includ
depress
anxieti
compuls
attent
deficit
hyperact
disord
adhd
substanc
abus
parkinson
diseas
schizophrenia
control
synapt
monoamin
level
affect
plasma
membran
monoamin
transport
mat
termin
action
biogen
amin
via
reuptak
presynapt
cell
mechan
action
drug
relat
medic
condit
typic
involv
mat
protein
tricycl
antidepress
tca
imipramin
tofranil
develop
allevi
depress
block
serotonin
norepinephrin
transport
sert
net
respect
therebi
extend
lifespan
synapt
serotonin
norepinephrin
unfortun
tca
also
block
adrenerg
muscarin
acetylcholin
histamin
receptor
respons
plethora
advers
effect
select
serotonin
reuptak
inhibitor
ssri
next
gener
antidepress
led
fluoxetin
prozac
carri
far
fewer
advers
effect
compar
tca
ssri
block
sert
result
surg
serotonin
activ
serotonin
receptor
type
drug
class
without
advers
effect
drive
forc
mat
uptak
monoamin
substrat
electrogen
har
inward
na
gradient
across
cell
membran
sert
net
dat
dopamin
transport
member
neurotransmitt
sodium
symport
nss
famili
well
member
larger
group
na
cl
depend
transport
known
solut
carrier
famili
lack
highresolut
mat
structur
hinder
structurefunct
therapeut
develop
effort
breakthrough
achiev
form
crystal
bacteri
nss
homolog
leut
leucin
transport
leut
xray
structur
provid
templat
build
credibl
mat
comput
model
although
model
qualiti
increas
sequenc
ident
templat
structur
similar
also
play
signific
role
absenc
highresolut
structur
sert
develop
ligand
base
pharmacophor
qsar
feasibl
altern
obtain
structur
inform
bind
pocket
ligandbas
approach
analyz
set
ligand
gener
possibl
proteinligand
interact
pattern
without
knowledg
protein
structur
limit
ligandbas
approach
flexibl
align
use
dissimilar
scaffold
less
reliabl
knowledg
bioactiv
conform
least
one
activ
molecul
significantli
improv
align
accuraci
limit
overcom
use
structurebas
approach
divers
scaffold
use
captur
ligand
interact
bind
pocket
environ
gener
dock
structurebas
techniqu
capabl
reliabl
predict
bioactiv
conform
cocrystal
ligand
absenc
experiment
structur
howev
reason
model
construct
receptor
use
crystallograph
nmr
data
genet
function
relat
protein
compar
model
correctli
predict
fold
protein
case
often
provid
insight
atomist
detail
ligand
bind
model
creat
method
identifi
potenti
bind
pocket
employ
dock
structurebas
pharmacophor
gener
virtual
screen
vs
identifi
new
ligand
interact
protein
pharmacophor
model
defin
collect
featur
essenti
bioactiv
ligand
wide
employ
approach
combin
pharmacophor
vs
yield
novel
structur
scaffold
ligand
target
receptor
applic
techniqu
dat
led
identif
structur
novel
vs
hit
compound
upon
modif
creat
potent
analog
ration
drug
design
present
work
describ
develop
structurebas
pharmacophor
vs
util
identifi
novel
ligand
structur
scaffold
display
sert
select
four
discret
amino
acid
sequenc
align
leut
gener
primarili
differ
loop
region
manual
refin
align
conduct
remov
gap
within
tm
region
rotam
residu
side
chain
line
hsert
halogenbind
pocket
select
base
abil
form
subpocket
residu
report
import
bind
certain
ssri
total
sert
homolog
model
built
use
discoveri
studio
ds
five
model
align
model
total
lowest
discret
optim
protein
energi
dope
score
chosen
evalu
dope
atomisticbas
statist
potenti
model
evalu
structur
predict
conform
energi
measur
reflect
stabil
model
rel
model
gener
model
also
deposit
pdb
evalu
server
assess
respect
stereochem
qualiti
access
sep
plot
gener
server
evalu
unusu
phipsi
angl
bond
length
bond
angl
van
der
waal
contact
two
model
select
evalu
specif
fit
environ
assess
ds
modul
assess
protein
tertiari
structur
compat
sequenc
final
spatial
overlap
model
templat
polypeptid
backbon
atom
examin
check
integr
model
tm
domain
volum
bind
pocket
basi
model
chosen
studi
moe
alpha
site
finder
use
identifi
possibl
ligand
site
model
site
expos
extracellular
space
chosen
base
evid
inhibitor
bind
vestibul
sphere
radiu
creat
constrain
result
dock
pose
keep
recent
report
combin
proxi
triangl
placement
method
forc
field
refin
affin
score
function
yield
moe
dock
pose
leucin
leut
rmsd
data
shown
strategi
next
use
dock
structur
divers
antidepress
figur
possess
larg
rang
sert
bind
affin
nm
nm
acknowledg
certain
ssri
ligand
use
dock
report
access
interior
substrat
pocket
howev
vs
pocket
employ
studi
contain
element
vestibular
substrat
pocket
halogen
bind
pocket
hbp
figur
latter
pocket
defin
part
hsert
residu
tm
tm
tm
ligandaccess
region
hbp
green
cloud
adjac
pocket
orang
cloud
figur
hbp
appear
import
recognit
halogencontain
inhibitor
pose
halogen
atom
ligand
direct
toward
pocket
thu
favor
consensu
develop
overlay
highestrank
pose
gener
common
interact
pattern
residu
identifi
common
interact
point
chosen
develop
pharmacophor
figur
pharmacophor
featur
radiu
creat
midway
tm
tm
captur
possibl
ionic
hbond
interact
particularli
proton
ligand
nitrogen
atom
previou
report
sertbas
pharmacophor
model
indic
import
posit
charg
nitrogen
atom
featur
radiu
creat
vicin
tm
captur
possibl
hbond
interact
lysin
side
chain
among
flexibl
natur
occur
amino
acid
rotam
possibl
rotam
orient
toward
vestibular
pocket
analog
leut
chosen
captur
possibl
interact
ligand
report
interact
differ
antidepress
leut
crystal
structur
thu
would
expect
play
similar
role
hsert
featur
radiu
creat
captur
hbond
interact
tm
residu
hsert
tm
analog
leut
residu
although
hsert
leut
differ
substanti
regard
natur
potenti
ligand
interact
featur
radiu
hbp
design
hydrophob
interact
believ
import
recogn
ssri
residu
line
pocket
conserv
hsert
leut
substitut
hsert
tm
residu
leut
alanin
phenylalanin
aspart
acid
increas
ssri
substrat
uptak
inhibit
potenc
fold
tm
mutat
hnet
hdat
observ
improv
ssri
affin
suggest
neg
influenc
methyl
side
chain
alanin
ssri
bind
final
exclus
volum
ad
make
pharmacophor
stringent
select
approxim
one
million
member
zinc
small
molecul
structur
librari
databas
screen
hsert
pharmacophor
possibl
hit
compound
predict
sert
ligand
total
molecul
accept
pharmacophor
filter
dock
subset
sert
model
follow
monitor
affin
dg
score
visual
inspect
result
pose
yield
prefer
compound
due
lack
avail
ten
top
compound
label
initi
test
hsert
hdat
hnet
affin
singl
point
vitro
bind
assay
two
compound
significantli
displac
cocain
analog
hsert
membran
indic
measur
hsert
affin
final
concentr
two
compound
displac
radioligand
hdat
hnet
cell
curious
displac
hdat
cell
alon
figur
dat
bind
affin
k
valu
mean
sem
dopamin
uptak
inhibit
potenc
ic
valu
observ
manuscript
prepar
character
hsert
membran
competit
assay
obtain
k
valu
inhibit
bind
hsert
k
valu
obtain
respect
figur
also
screen
abil
inhibit
uptak
h
serotonin
intact
hsert
cell
inhibit
h
serotonin
uptak
detect
final
concentr
employ
two
vs
hit
compound
figur
ic
valu
obtain
given
structur
flexibl
figur
greatli
differ
ssri
tca
employ
develop
pharmacophor
given
high
sequenc
similar
calcul
blast
among
threehmat
find
specif
inhibitor
target
singl
transport
challeng
task
vs
precari
addit
inhibitor
bind
pocket
uncertainti
associ
homolog
model
built
use
templat
share
sequenc
ident
figur
handicap
goal
studi
identifi
sert
ligand
novel
structur
scaffold
high
concentr
vs
hit
compound
rel
sert
ligand
radiotrac
employ
pharmacolog
screen
observ
vs
hit
show
abil
displac
radioligand
serthek
cell
confirm
huge
molar
ratio
vs
compound
radiotrac
insuffici
decreas
radiotrac
bind
ie
sert
affin
requir
regist
respons
assay
two
vs
hit
pharmacolog
verifi
sert
ligand
display
micromolar
k
valu
bind
affin
low
compar
nanomolar
better
sert
affin
certain
ssri
therapeut
inhibit
serotonin
uptak
observ
vs
hit
compound
screen
concentr
substrat
uptak
inhibit
potenc
often
lower
bind
affin
given
mat
inhibitor
possibl
due
differ
mat
conform
popul
requir
two
process
concentr
employ
may
threshold
detect
sert
ligand
bind
threshold
detect
serotonin
uptak
inhibit
micromolar
affin
vs
hit
compound
common
homolog
model
employ
research
team
first
report
vs
effort
base
dat
homolog
model
yield
hit
compound
low
micromolar
dat
affin
slightli
better
high
nanomolar
sert
affin
without
modif
compound
display
antipsychostimul
antidepress
properti
ref
unpublish
data
vs
effort
use
dat
model
yield
hit
compound
sert
k
valu
nm
analog
design
increas
sert
select
result
compound
sert
k
valu
nm
sert
dat
sert
net
select
ratio
respect
thu
vs
hit
compound
micromolar
affin
appear
use
lead
compound
medic
develop
knowledg
first
studi
identifi
novel
sertselect
reuptak
inhibitor
vs
perform
hsert
homolog
model
convent
drug
develop
usual
involv
creation
analog
establish
ligand
given
receptor
contrast
vs
approach
afford
possibl
discov
ligand
differ
scaffold
ligand
likelihood
would
never
otherwis
identifi
receptor
case
sert
inhibitor
novel
scaffold
provid
new
opportun
develop
ration
design
multisit
drug
eg
blocker
address
therapeut
goal
mitig
advers
effect
associ
ssri
drug
class
anticip
two
sm
compound
describ
herein
serv
lead
compound
toward
treatment
depress
anxieti
serotoninrel
disord
polypeptid
sequenc
retriev
alignmentth
fasta
sequenc
human
sert
download
uniprot
databas
access
number
xray
crystal
structur
aquifex
aeolicu
protein
leut
use
templat
download
protein
data
bank
pdb
templat
check
miss
residu
use
protein
report
util
modul
discoveri
studio
ds
prior
model
effort
miss
residu
second
extracellular
loop
built
leut
templat
subject
ds
loop
refin
protocol
differ
hsert
model
creat
use
methodolog
three
previous
propos
sequenc
align
hsert
model
manep
et
al
align
articl
sequenc
hsert
modifi
leut
align
use
align
sequenc
templat
protocol
ds
align
similar
celik
et
al
gener
minor
manual
modif
increas
sequenc
ident
leut
figur
nand
ctermin
overhang
delet
increas
sequenc
ident
sequenc
similar
hsert
model
sequenc
began
ntermin
tail
end
ctermin
tail
build
homolog
model
protocol
ds
employ
model
version
use
construct
hsert
model
model
refin
see
model
valid
rank
discret
optim
protein
energi
dope
score
model
best
dope
score
design
model
hsert
model
beum
et
al
alignmentth
hsert
queri
sequenc
modifi
leut
load
ds
align
describ
beum
et
al
termin
residu
match
templat
coordin
end
omit
model
built
assign
dope
score
describ
model
base
align
result
posit
directli
substrat
permeat
pore
would
like
influenc
ligand
dock
dangl
adjust
use
ds
loop
refin
protocol
model
evalu
use
verifi
protein
protocol
assess
score
residu
known
environ
follow
superposit
hsert
model
onto
leut
check
tm
domain
coincid
final
version
design
model
hsert
model
yamashita
et
al
alignmentth
hsert
queri
sequenc
modifi
templat
align
propos
yamashita
et
al
nand
ctermin
overhang
delet
leav
hsert
residu
optim
model
result
align
design
model
hsert
model
celik
et
al
alignmenttwenti
hsert
model
built
ds
describ
follow
propos
celik
et
al
align
offer
sequenc
ident
match
compar
manep
align
greater
beum
yamashita
align
hsert
polypeptid
use
develop
model
describ
model
five
model
four
align
group
chosen
base
dope
score
stereochem
qualiti
prefer
model
assess
valid
server
use
evalu
structur
deposit
pdb
group
five
two
model
chosen
base
fewest
outlier
phipsi
angl
ramachandran
plot
two
model
evalu
fold
use
verifi
protein
protocol
ds
protocol
reduc
structur
simplifi
represent
compar
amino
acid
sequenc
assign
score
score
compar
expect
high
low
score
sequenc
predict
statist
analysi
highresolut
pdb
structur
tm
domain
assembl
ligand
bind
pocket
volum
check
superpos
sert
model
onto
leut
model
use
moe
figur
singl
hsert
model
select
four
group
allatom
forc
field
use
add
hydrogen
atom
partial
charg
model
keep
nonhydrogen
atom
fix
space
hydrogen
atom
minim
converg
criterion
kcal
mol
final
hsert
model
chosen
align
optim
minim
outlier
avoid
unnecessari
protein
contact
four
model
model
smallest
rmsd
superposit
leut
maxim
ligand
bind
pocket
volum
similar
leut
alpha
site
finder
function
moe
use
identifi
possibl
ligand
bind
site
model
site
finder
pure
geometr
energi
term
use
alpha
sphere
within
hsert
model
expos
solvent
elimin
sphere
correspond
locat
tight
atom
pack
model
retain
sphere
classifi
either
hydrophob
hydrophil
depend
potenti
hydrogen
bond
follow
default
set
alpha
sphere
cluster
produc
collect
put
bind
site
rank
accord
number
hydrophob
atom
within
contact
distanc
sphere
final
dummi
atom
creat
pocket
specifi
algorithm
dock
ligand
ligand
coordin
obtain
small
molecul
crystal
databas
ccsd
cambridg
crystallograph
structur
databas
ligand
coordin
drawn
use
moe
partial
charg
hydrogen
atom
ad
ligand
use
merck
molecular
forc
field
ligand
geometri
optim
via
energi
minim
conjug
gradient
truncat
newton
optim
algorithm
converg
criteria
kcalmol
leucin
select
tca
drug
first
dock
leut
model
test
consist
report
cocryst
structur
atom
placement
method
includ
proxi
triangl
alpha
triangl
triangl
matcher
employ
refin
techniqu
use
gridbas
forc
fieldbas
method
combin
produc
pose
close
crystal
structur
chosen
hsert
dock
interact
plot
dock
pose
differ
antidepress
hsert
gener
use
moe
ligand
interact
modul
consensu
residu
predict
ligand
interact
develop
use
creat
pharmacophor
featur
vestibular
ligandbind
pocket
pharmacophor
featur
gener
amino
acid
side
chain
ligand
interact
point
obtain
initi
dock
iter
pharmacophor
point
radiu
radiu
delin
better
encompass
hydrophob
featur
dock
ligand
exclud
volum
creat
algorithm
assign
penalti
pose
encroach
space
final
pharmacophor
product
test
use
databas
contain
known
hsert
ligand
decoy
ligand
pharmacophor
model
success
discrimin
classic
hsert
ligand
decoy
million
entri
allpurchas
subset
zinc
databas
contain
download
subset
wash
import
collect
moe
remov
unwant
salt
ion
disconnect
molecular
fragment
databas
lipinski
rule
five
descriptor
appli
databas
remov
nondruglik
molecul
compound
reactiv
group
remov
screen
databas
use
toxic
moieti
descriptor
databas
subset
contain
approxim
one
million
compound
select
use
tautom
protom
entri
gener
physiolog
ph
use
import
conform
modul
moe
differ
conform
gener
minim
use
forc
field
conform
strain
energi
kcalmol
lowest
energi
conform
discard
final
databas
screen
use
pharmacophor
hit
compound
accept
pharmacophor
filter
screen
ensur
presenc
halogen
molecular
weight
dalton
featur
common
known
antidepress
step
yield
pool
hit
compound
three
hsert
dock
iter
perform
pool
structur
affin
score
kcalmol
plu
visual
inspect
use
condens
pool
candid
ligand
toprank
compound
code
procur
variou
sourc
pharmacolog
test
vitro
vs
compound
bind
screencompound
identifi
virtual
screen
purchas
dissolv
dmso
concentr
mm
initi
onepoint
competit
bind
assay
conduct
use
final
concentr
vs
hit
compound
nm
radiolabel
cocain
analog
radioligand
high
affin
three
mat
stabli
transfect
membran
whole
cell
employ
bind
assay
nonspecif
bind
determin
inclus
paroxetin
mazindol
desipramin
hsert
hdat
hnet
assay
respect
screen
result
analyz
oneway
anova
p
posthoc
dunnett
multipl
comparison
test
hsert
membran
bind
assayhsert
bind
affin
obtain
displac
membran
bind
assay
membran
prepar
stabl
hserthek
cell
grown
co
environ
mm
plate
confluenc
day
growth
cell
wash
twice
ml
cold
phosphatebuff
salin
dpb
addit
ml
dpb
ad
cell
harvest
scrape
transfer
cold
centrifug
tube
ml
follow
centrifug
min
low
speed
g
remov
supernat
cell
pellet
resuspend
ul
cold
te
buffer
mm
tri
mm
edta
ph
follow
centrifug
min
g
supernat
discard
pellet
frozen
later
use
resuspend
icecold
bind
buffer
mm
tri
ph
mm
nacl
sampl
analyz
protein
content
use
bradford
protein
assay
competit
bind
membran
incub
nm
concentr
increas
concentr
cold
competitor
nm
mm
paroxetin
measur
nonspecif
bind
reaction
carri
mm
borosil
glass
tube
gentl
shake
room
temperatur
hour
termin
rapid
filtrat
gfb
filter
schleicher
schuell
keen
nh
presoak
polyethylenimin
solut
vv
filter
wash
twice
ml
cold
mm
tri
buffer
transfer
vial
radioact
determin
use
beckman
gamma
counter
satur
bind
assay
data
analyz
graphpad
prism
softwar
ic
valu
gener
convert
k
valu
use
chengprusoff
equat
k
ic
k
hdat
hnet
whole
cell
bind
assayswholecel
competit
bind
assay
perform
hdat
hnet
use
stabl
cell
line
respect
grown
co
environ
cell
monolay
grown
plate
confluenc
cell
wash
twice
ml
krh
buffer
mm
hepe
ph
mm
nacl
mm
kcl
mm
cacl
mm
mgso
mm
kh
po
mm
glucos
supplement
mm
ascorb
acid
krhaa
cell
incub
minut
nm
supplement
tropolon
total
volum
ul
along
increas
concentr
drug
mazindol
hdat
desipramin
hnet
follow
incub
cell
wash
twice
ml
krhaa
buffer
treat
ml
sd
gentl
shake
room
temperatur
hour
cell
lysat
transfer
vial
radioact
determin
use
beckman
gamma
counter
analyz
use
graphpad
prism
describ
serotonin
uptak
inhibit
screenonepoint
competit
bind
assay
perform
use
stabli
transfect
whole
cell
grown
confluenc
plate
cell
wash
krh
buffer
preincub
vs
hit
compound
min
follow
addit
nm
h
serotonin
addit
min
cell
wash
twice
treat
sd
shaken
hr
lysat
transfer
ml
scintil
fluid
radioact
detect
use
beckman
liquid
scintil
counter
nonspecif
radioligand
uptak
determin
presenc
clomipramin
chemic
structur
sert
inhibitor
use
develop
pharmacophor
data
present
mean
sem
analyz
oneway
anova
dunnett
multipl
comparison
posthoc
test
p
vs
total
bind
assay
p
vs
total
bind
assay
vs
hit
compound
vitro
serotonin
uptak
inhibit
screen
compound
final
concentr
test
abil
inhibit
h
serotonin
uptak
hsert
cell
nonspecif
radioligand
uptak
assess
presenc
paroxetin
par
data
repres
independ
experi
perform
duplic
data
present
mean
sem
analyz
oneway
anova
dunnett
multipl
comparison
posthoc
test
p
vs
total
uptak
assay
p
vs
total
uptak
assay
align
leut
aa
hsert
amino
acid
sequenc
use
build
model
ident
blue
similar
red
align
residu
indic
dot
star
correspond
residu
line
pocket
respect
transmembran
connect
loop
topolog
display
sequenc
gap
rel
sequenc
repres
dot
posit
residu
respect
chain
indic
line
sequenc
figur
prepar
use
texshad
